Informationen:
Fehler:
ID
34697
Beschreibung
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121); ODM derived from: https://clinicaltrials.gov/show/NCT01076088
Link
https://clinicaltrials.gov/show/NCT01076088
Stichworte
Versionen (1)
- 23.01.19 23.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
23. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type 2 Diabetes Mellitus NCT01076088
Eligibility Type 2 Diabetes Mellitus NCT01076088
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type 2 Diabetes Mellitus NCT01076088
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
has type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Gender | Female infertility | Gender Contraceptive methods
Item
is male, a female who cannot have children, or a female who agrees to use birth control during the study
boolean
C0079399 (UMLS CUI [1])
C0021361 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0021361 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Hypoglycemic Agents Absent | Hemoglobin A1c measurement | Oral hypoglycemic Single | Hypoglycemic Agents Low dose Combined Modality Therapy
Item
is not on an antihyperglycemic agent (aha) (hemoglobin a1c [a1c] 7.5-11.0%) or on oral single aha (a1c 7.0-10.5%) or low-dose aha combination therapy (a1c 7.0-10.0%)
boolean
C0020616 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
C0359086 (UMLS CUI [3,1])
C0205171 (UMLS CUI [3,2])
C0020616 (UMLS CUI [4,1])
C0445550 (UMLS CUI [4,2])
C0009429 (UMLS CUI [4,3])
C0332197 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
C0359086 (UMLS CUI [3,1])
C0205171 (UMLS CUI [3,2])
C0020616 (UMLS CUI [4,1])
C0445550 (UMLS CUI [4,2])
C0009429 (UMLS CUI [4,3])
Diabetes Mellitus, Insulin-Dependent | Ketoacidosis
Item
patient has type 1 diabetes mellitus or ketoacidosis
boolean
C0011854 (UMLS CUI [1])
C0220982 (UMLS CUI [2])
C0220982 (UMLS CUI [2])
Dipeptidyl-Peptidase IV Inhibitors | Sitagliptin
Item
patient is taking a dipeptidyl peptidase-4 (dpp-4) inhibitor (such as sitagliptin)
boolean
C1827106 (UMLS CUI [1])
C1565750 (UMLS CUI [2])
C1565750 (UMLS CUI [2])
Weight Reduction Program | Maintenance Phase Absent | Weight-Loss Agents
Item
patient is on a weight loss program not in the maintenance phase or on a weight loss medication
boolean
C3179079 (UMLS CUI [1])
C0024501 (UMLS CUI [2,1])
C0205390 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0376606 (UMLS CUI [3])
C0024501 (UMLS CUI [2,1])
C0205390 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0376606 (UMLS CUI [3])
Liver disease | Heart failure | Heart Disease | Cerebrovascular accident | Hypertensive disease | Hematological Disease | Malignant Neoplasms
Item
patient has a history of liver disease, heart failure, heart disease, stroke, high blood pressure, blood disorders, or cancer
boolean
C0023895 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0020538 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C0006826 (UMLS CUI [7])
C0018801 (UMLS CUI [2])
C0018799 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0020538 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C0006826 (UMLS CUI [7])
HIV Seropositivity
Item
patient is hiv positive
boolean
C0019699 (UMLS CUI [1])
Pregnancy
Item
patient is pregnant
boolean
C0032961 (UMLS CUI [1])